Pharmafile Logo
Pharmafocus logo
Advanced Search

Contract Manufacturing

Showing 4 posts of 4 posts found.

Christopher Conway joins BioDuro board to strengthen global leadership

August 21, 2025 Contract Manufacturing, Manufacturing and Production Bio X Cell, BioDuro, Corporate, board of directors, contract research development and manufacturing organisation

BioDuro has announced the appointment of Christopher Conway, CEO of Bio X Cell, to its board of directors, effective immediately. …
Appointment

Sanner appoints new CEO to drive CDMO strategy

August 11, 2025 Contract Manufacturing, Manufacturing and Production CEO, Corporate, Sanner, contract development and manufacturing organisation

German packaging solutions company, Sanner, has announced a significant leadership change as it advances its transformation into a contract development …
Appointment

ViroCell Biologics and AvenCell Therapeutics partner to accelerate allogeneic CAR-T therapy development

July 29, 2025 Contract Manufacturing, Manufacturing Services, Mergers and Acquisitions, Research and Development AvenCell Therapeutics, CAR-T therapy, Contract Development Manufacturing Organisation, Good Manufacturing Practice, Immunology, Oncology, ViroCell Biologics, autoimmune diseases, blood cancer

ViroCell Biologics has announced a new manufacturing collaboration with AvenCell Therapeutics to produce a high-yield retroviral vector supporting the clinical …
News

Ascend granted certification for quality control testing at Munich facility

June 12, 2025 Contract Manufacturing, Manufacturing Services, Manufacturing and Production Adeno-associated (AAV)-based gene therapy., Ascend Advanced Therapeutics, Devices, Pharmacy, adeno-associated gene therapy, contract development and manufacturing organisation, good manufacturing practice certification, manufacturing site

Ascend Advanced Therapies, a contract development and manufacturing organisation based in Maryland, US, has received good manufacturing practice (GMP) certification …
News
The Gateway to Local Adoption Series

Latest content

BMS’ Opdivo/Yervoy combination accepted by Scottish Medicines Consortium for colorectal cancer

February 5, 2026

AstronauTx appoints Adam Rosenberg as Chair of the Board

February 5, 2026

Astellas Pharma’s Vyloy accepted by Scottish Medicines Consortium for gastric cancer

February 4, 2026

Angelini Pharma appoints Sergio Marullo di Condojanni as CEO

February 4, 2026

QV Bioelectronics secures £4.5m in funding for brain cancer therapy development

February 3, 2026